Valneva SE (VALN)
8.69
-0.19
(-2.14%)
USD |
NASDAQ |
May 20, 12:21
Valneva Market Cap: 604.62M for May 20, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 17, 2024 | 617.84M |
| May 16, 2024 | 613.32M |
| May 15, 2024 | 615.75M |
| May 14, 2024 | 557.31M |
| May 13, 2024 | 529.48M |
| May 10, 2024 | 516.24M |
| May 09, 2024 | 495.38M |
| May 08, 2024 | 503.73M |
| May 07, 2024 | 521.82M |
| May 06, 2024 | 521.82M |
| May 03, 2024 | 536.43M |
| May 02, 2024 | 516.67M |
| May 01, 2024 | 526.69M |
| April 30, 2024 | 518.34M |
| April 29, 2024 | 535.04M |
| April 26, 2024 | 531.55M |
| April 25, 2024 | 525.30M |
| April 24, 2024 | 539.22M |
| April 23, 2024 | 538.71M |
| April 22, 2024 | 551.04M |
| April 19, 2024 | 527.62M |
| April 18, 2024 | 565.65M |
| April 17, 2024 | 539.22M |
| April 16, 2024 | 556.60M |
| April 15, 2024 | 591.40M |
| Date | Value |
|---|---|
| April 12, 2024 | 592.09M |
| April 11, 2024 | 618.53M |
| April 10, 2024 | 588.80M |
| April 09, 2024 | 559.50M |
| April 08, 2024 | 599.05M |
| April 05, 2024 | 573.31M |
| April 04, 2024 | 566.00M |
| April 03, 2024 | 574.70M |
| April 02, 2024 | 537.13M |
| April 01, 2024 | 534.35M |
| March 28, 2024 | 549.60M |
| March 27, 2024 | 552.03M |
| March 26, 2024 | 542.66M |
| March 25, 2024 | 541.62M |
| March 22, 2024 | 533.64M |
| March 21, 2024 | 514.21M |
| March 20, 2024 | 492.70M |
| March 19, 2024 | 549.60M |
| March 18, 2024 | 535.96M |
| March 15, 2024 | 535.03M |
| March 14, 2024 | 515.25M |
| March 13, 2024 | 518.37M |
| March 12, 2024 | 511.78M |
| March 11, 2024 | 512.13M |
| March 08, 2024 | 501.02M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
460.78M
Minimum
Mar 06 2024
3.530B
Maximum
Nov 29 2021
1.196B
Average
992.45M
Median
Sep 13 2022
Market Cap Benchmarks
| DBV Technologies SA | 124.22M |
| Cellectis SA | 213.70M |
| PHAXIAM Therapeutics SA (DELISTED) | -- |
| Genfit SA | 201.44M |
| Innate Pharma SA | 236.06M |
Market Cap Related Metrics
| PS Ratio | 3.656 |
| Price to Book Value | 2.959 |
| Price | 8.69 |
| Earnings Yield | -4.73% |